Retinoic acid induces functional c-Ret tyrosine kinase in human neuroblastoma

被引:9
|
作者
Yamada, Shigeru [1 ]
Nomura, Takashi [1 ]
Uebersax, Lorenz [1 ]
Matsumoto, Kayo [1 ]
Fujita, Satoshi [1 ]
Miyake, Masato [1 ]
Miyake, Jun [1 ]
机构
[1] Natl Inst Adv Ind Sci & Technol, RICE, Kohoku Ku, Tokyo 1350064, Japan
关键词
c-Ret tyrosine kinase; cell survival; glial cell line-derived neurotrophic factor; neurite outgrowth; neuroblastoma; retinoic acid;
D O I
10.1097/WNR.0b013e32801299b4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
After the treatment of human neuroblastorna SH-SY5Y cells with retinoic acid for 24h, the expression of c-Ret receptor tyrosine kinase was greatly elevated. Treatment of SH-SYSY cells with glial cell line-derived neurotrophic factor under serum-free conditions after incubation of cells with retinoic acid resulted in the phosphorylation of c-Ret receptor tyrosine kinase, with subsequent morphological changes that included formation of neurites and rounding of cell bodies within 24-48h. The number of neurite-bearing cells decreased with increasing concentrations of mitogen-activated protein kinase-specific and phosphatidylinositol 3-kinase inhibitors. These observations suggest that retinoic acid induces the expression of glial cell line-derived neurotrophic factor-responsive c-Ret receptor tyrosine kinase and that a glial cell line-derived neurotrophic factor-c-Ret receptor tyrosine kinase-induced signal transduction system that might be involved in neurite outgrowth via pathways that include phosphaticlylinositol 3-kinase and mitogen-activated protein kinase.
引用
收藏
页码:359 / 363
页数:5
相关论文
共 50 条
  • [31] EXPRESSION OF THE RET PROTOONCOGENE IN HUMAN NEUROBLASTOMA CELL-LINES AND ITS INCREASE DURING NEURONAL DIFFERENTIATION INDUCED BY RETINOIC ACID
    TAHIRA, T
    ISHIZAKA, Y
    ITOH, F
    NAKAYASU, M
    SUGIMURA, T
    NAGAO, M
    ONCOGENE, 1991, 6 (12) : 2333 - 2338
  • [32] Ret: a receptor tyrosine kinase and its mutation and human diseases.
    Mao, JP
    Sun, ZX
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 1998, 25 (06) : 513 - 517
  • [33] EFFECTS OF RETINOIC ACID AND STAUROSPORINE ON THE PROTEIN KINASE-C ACTIVITY AND THE MORPHOLOGY OF 2 RELATED HUMAN NEUROBLASTOMA CELL-LINES
    SLACK, RS
    PROULX, P
    BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1053 (01) : 89 - 96
  • [34] GFRα-4 and the tyrosine kinase Ret form a functional receptor complex for persephin
    Enokido, Y
    de Sauvage, F
    Hongo, JA
    Ninkina, N
    Rosenthal, A
    Buchman, VL
    Davies, AM
    CURRENT BIOLOGY, 1998, 8 (18) : 1019 - 1022
  • [35] Retinoic acid induces sensitization of cyclic AMP formation in a neuroblastoma cell line
    Ibrisimovic, E.
    Malaga-Dieguez, L.
    Nanoff, C.
    PHARMACOLOGY, 2006, 78 (03) : 148 - 148
  • [36] 13-CIS RETINOIC ACID INDUCES DIFFERENTIATION OF THREE TYPES OF HUMAN NEUROBLASTOMA CELL LINES IN VITRO
    Shao, J.
    Jiang, H.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S334 - S334
  • [37] Glial cell line-derived neurotrophic factor neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFRα-1, and GFRα-2
    Hishiki, T
    Nimura, Y
    Isogai, E
    Kondo, K
    Ichimiya, S
    Nakamura, Y
    Ozaki, T
    Sakiyama, S
    Hirose, M
    Seki, N
    Takahashi, H
    Ohnuma, N
    Tanabe, M
    Nakagawara, A
    CANCER RESEARCH, 1998, 58 (10) : 2158 - 2165
  • [38] A novel therapeutic combination for neuroblastoma: The RET inhibitor ZD6474 with cis-retinoic acid
    Zeng, Lizhi
    Nilsson, Monique B.
    Heymach, John V.
    Zage, Peter E.
    Zweidler-McKay, Patrick A.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 640 - 640
  • [39] Physical and functional interaction between protein kinase C δ and Fyn tyrosine kinase in human platelets
    Crosby, D
    Poole, AW
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (27) : 24533 - 24541
  • [40] The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma
    Oppenheimer, Orit
    Cheung, Nai-Kong
    Gerald, William L.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (04) : 1300 - 1309